IRVINE, Calif., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK) today announced the executive offices of the Company have been relocated to Irvine, California. Current research will remain headquartered in Iowa while executive offices are now closer to the Company's executives in California. Additionally the Company will initiate investor outreach initiatives as Vivakor continues to execute on its business plan and develop commercialization outlets, and partners, for Vivakor technologies. Chairman Matt Nicosia added the following statement, "This move in executive offices will allow the company to attract further management and personnel needed to continue Vivakor's business plan. We are aware that management needs to improve its investor relations, and with the goal to add additional executives, the Company will commence an investor outreach program."
About Vivakor, Inc.
Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at .
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
CONTACT: Vivakor, Inc. Vivakor Investor Relations (888) 648-8485